Invert

Biomanufacturing solutions for sustainable materials

San Francisco, California, United States

About Invert

InvertBio focuses on biomanufacturing, which uses biological processes to produce materials and chemicals. This method allows industries like manufacturing, agriculture, and pharmaceuticals to create physical inputs in a more sustainable and efficient way, reducing environmental impact and costs. InvertBio's technology is scalable, meaning it can grow to meet increasing demand. The company aims to address global challenges such as climate change and poverty by providing a viable alternative to traditional manufacturing processes. Its goal is to lead the transition towards greener industrial practices by offering its biomanufacturing services to various sectors.

San Francisco, CaliforniaHeadquarters
2021Year Founded
$19.6MTotal Funding
EARLY_VCCompany Stage
Industrial & Manufacturing, BiotechnologyIndustries
11-50Employees

Benefits

Remote Work Options
Unlimited Paid Time Off
Company Equity

Risks

Technological advancements could render InvertBio's platform obsolete if not updated.
Data privacy regulations may limit microbial genomics and bioprocess data integration.
Intensifying competition in biomanufacturing could erode InvertBio's market share.

Differentiation

Invert connects microbial genomics with bioprocess data, eliminating data silos.
InvertBio focuses on sustainable biomanufacturing, addressing global challenges like climate change.
Invert's platform enables bioindustrial companies to analyze process data without coding.

Upsides

InvertBio raised $20.1M to expand and accelerate product development.
Growing interest in bio-based materials aligns with InvertBio's sustainability focus.
Increased venture capital investment indicates strong growth potential in biomanufacturing.

Funding

Total raised$19.60 M
Latest valuation$100.75 M
StageEARLY_VC
EARLY VC
6/30/2024
$20
$100.75 M